Trial · NCT05280743
Precision Opioid Care After Cesarean Delivery (PRECISE-CD)
NCT05280743, Completed, Grace Lim, MD, MS
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Precision Opioid Care After Cesarean Delivery (PRECISE-CD). Trials, record NCT05280743. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05280743
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Precision Opioid Care After Cesarean Delivery (PRECISE-CD)
- NCT number
- NCT05280743
- Status
- Completed
- Enrollment
- 341 participants, actual
- Lead sponsor
- Grace Lim, MD, MS
- Conditions
- Cesarean Section Complications, Opioid Use
- Interventions
- Oxycodone
- First posted
- 2022-03-15
- Last updated
- 2024-07-05
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Opioid-Induced Adverse Effects-PROPORTION of maternal participants with RD | From time of surgery to time of discharge up to 3 days post-surgery | Respiratory depression (RD) measured as Yes or No in occurrence. |
| Primary | Opioid-Induced Adverse Effects-PROPORTION of maternal participants with PONV | From time of surgery to time of discharge up to 3 days post-surgery | Postoperative Nausea and Vomiting (PONV) Intensity Scale. Participants will be categorized as Clinically relevant (Yes) or Not clinically relevant (No) Nausea and Vomiting from the PONV scale. Clinically important PONV is defined as a total score \>50 at any time throughout the study period. |
| Secondary | Maternal Post-operative Pain Scores | From time of delivery to 12-month post-surgery | Numerical Rating Scale (NRS). The pain scale is from 0 to 10, 0 being "no pain" and 10 being "the worst pain imaginable" |
| Secondary | Total Maternal Inpatient Opioid Use | From time of surgery to discharge-- up to 3 days post-surgery | measured in milligrams of Morphine Equivalents |
| Secondary | Extended Hospital Length of Stay-Maternal | From surgery to 72 hours postoperation | Yes/No Proportion of Women discharged beyond 72-hours post-surgery |
| Secondary | Length of prescribed opioid use (For Mothers; in days) | From day of surgery to 12-month post-surgery | Number of days patients take opioids post-surgery. |
| Secondary | Neonatal Sedation-- PROPORTION of infants with Sedation | From birth to 7-days post-birth | Defined as YES (any sleeping \> 4 hours in hospital or first week of life) or NO (sleeping) less than 4 hours at a time. |
| Secondary | Neonatal Respiratory Depression--PROPORTION of neonates diagnosed with RD | From birth to time of discharge (up to 3 days post-birth) | Yes/No Yes: Defined as respiratory rate 8 or fewer breaths per minute |
| Secondary | Extended Hospital Length of Stay-Neonate | From time of delivery to 72-hours post-delivery | Yes/No Proportion of neonates staying in hospital longer than 72-hours (Yes) |
| Secondary | Neonatal Limpness (reporting limpness > 0, or not limp =0) | From birth to 72-hours post-delivery | Proportion of Infants with Limpness reported |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05280743
GET https://conductscience.org/api/trials/v1/NCT05280743/registered